EP08.02-082 Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
J.Y. Lee, G. Liu, F.A. Shepherd, Abhinav Thakral(University of California San Francisco Medical Center), K. Balaratnam, S. Cheng, N. Leighl, L. Zhan, M. Garcia, L. Corke, V. Mai, M.C. Brown, P. Bradbury, K. Khan, A. Sacher(University of Toronto)
Cited by 6
Related Papers
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2025|74
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study
|Nature Communications|2024|42
National, regional, and global statistics on alcohol consumption and associated burden of disease 2000–20: a modelling study and comparative risk assessment
|The Lancet Public Health|2025|21
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancer
|Journal of Pharmacology and Experimental Therapeutics|2024|4
EP11.02-001 Natural Language Processing to Abstract Preneoplastic and Incidental Pulmonary Lesions from Pathology Reports
|Journal of Thoracic Oncology|2022|0